The first patient with small cell lung cancer has been dosed in a trial of peluntamig (PT217) combined with chemotherapy.

The first patient has been dosed in a first-in-human clinical trial evaluating HLD-0915 for metastatic castration-resistant ...

Dr. Frederick L. Locke sat down with CURE® to discuss treatment with cema-cel in the ALPHA/ALPHA2 studies for ...

Camizestrant with a CDK 4/6 inhibitor had a statistically significant and clinically meaningful improvement in PFS in ...

Chemoradiation improves survival in cervical cancer patients, but benefits may decline after age 80, according to a study ...

I was told my lymphoma had worsened, but a miraculous turn of events spared me from aggressive chemotherapy, making me ...

Dr. Chandler Park helps patients with genitourinary cancers, including both prostate and bladder, understand the importance ...

For female patients with glioma, pregnancy after receiving a diagnosis of glioma is associated with worse progression-free ...

Fractionated reirradiation is safe and feasible, suggesting higher reirradiation dose may be feasible in patients with ...

After realizing that a stronger support system would have helped me emotionally and spiritually in my cancer journey, I ...

An expert shares information on a pair of noteworthy active trials in breast cancer that patients should be aware of.

The addition of ctDNA testing to radiographic surveillance resulted in curative surgical intervention for 1.6% of patients ...